ALLO : Allogene Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-31 |
|---|---|---|---|---|
| 2023 | $3.98 | $3.75 | $4.57 | -19.48% |
| 2024 | $4.38 | $3.93 | $4.94 | -11.41% |
| 2025 | $5.37 | $5.11 | $5.54 | 8.63% |
| 2026 | $6.06 | $5.31 | $6.53 | 22.76% |
| 2027 | $6.91 | $6.56 | $7.31 | 39.81% |
| 2028 | $7.49 | $7.35 | $7.64 | 51.61% |
| 2029 | $7.75 | $7.67 | $7.81 | 56.96% |
| 2030 | $7.53 | $7.21 | $7.72 | 52.49% |
| 2031 | $6.74 | $6.5 | $7.11 | 36.38% |
| 2032 | $5.43 | $4.15 | $6.43 | 9.91% |
| 2033 | $3.72 | $3.52 | $3.95 | -24.68% |
The 16 Wall Street analysts offering Allogene Therapeutics stock forecast in the last 6 months have average price target of
$18.31 with a high forecast of $31.0 and a low forecast of $6.0.
The average Allogene Therapeutics stock forecast represents a 270.65%
increase from the last price of $4.94000005722046.
From AI system, total return is 2366.52% from 4098 forecasts.
For Allogene Therapeutics stock forecast for 2023, 8 predictions are offered for each month of 2023 with average Allogene Therapeutics stock
forecast of $3.98, a high forecast of $4.57, and a low forecast of $3.75.
The average Allogene Therapeutics stock forecast 2023 represents a -19.48%
decrease from the last price of $4.94000005722046.
For Allogene Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Allogene Therapeutics stock
forecast of $4.38, a high forecast of $4.94, and a low forecast of $3.93.
The average Allogene Therapeutics stock forecast 2024 represents a -11.41%
decrease from the last price of $4.94000005722046.
For Allogene Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Allogene Therapeutics stock
forecast of $6.06, a high forecast of $6.53, and a low forecast of $5.31.
The average Allogene Therapeutics stock forecast 2026 represents a 22.76%
increase from the last price of $4.94000005722046.
For Allogene Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Allogene Therapeutics stock
forecast of $7.49, a high forecast of $7.64, and a low forecast of $7.35.
The average Allogene Therapeutics stock forecast 2028 represents a 51.61%
increase from the last price of $4.94000005722046.
For Allogene Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Allogene Therapeutics stock
forecast of $6.74, a high forecast of $7.11, and a low forecast of $6.5.
The average Allogene Therapeutics stock forecast 2031 represents a 36.38%
increase from the last price of $4.94000005722046.
For Allogene Therapeutics stock forecast for 2033 (10 year), 4 predictions are offered for each month of 2033 with average Allogene Therapeutics stock
forecast of $3.72, a high forecast of $3.95, and a low forecast of $3.52.
The average Allogene Therapeutics stock forecast 2033 represents a -24.68%
decrease from the last price of $4.94000005722046.
Please, see more forecasts below.
ALLO : Allogene Therapeutics stock forecast by Wall Street Analysts
The average Allogene Therapeutics stock forecast from last 6 month is $18.31, and this show a -23.97% decrease in average from the prior price target of the each prediction. Also, this average forecast of $18.31 represents a -14.56% decrease from the past average forecast of $21.43, 6 months ago from 7 wall street analysts.
Allogene Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-04-03 | $5.28 | 6.91% |
| 2023-04-04 | $5.46 | 3.42% |
| 2023-04-05 | $5.54 | 1.51% |
| 2023-04-06 | $5.62 | 1.45% |
| 2023-04-07 | $5.70 | 1.40% |
ALLO : Long term Allogene Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 May. is $4.57 , for 2024 Apr. is $4.20 , for 2027 Apr. is $6.67 , for 2028 Apr. is $7.43 , for 2032 Apr. is $6.10 , and for 2033 Apr. is $3.52.
ALLO : Allogene Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 May. | $4.57 | -7.40% |
| 2023 Jun. | $4.26 | -6.91% |
| 2023 Jul. | $4.00 | -6.02% |
| 2023 Aug. | $3.83 | -4.35% |
| 2023 Sep. | $3.75 | -1.99% |
| 2023 Oct. | $3.76 | 0.14% |
| 2023 Nov. | $3.80 | 1.01% |
| 2023 Dec. | $3.85 | 1.57% |
ALLO : Allogene Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $3.93 | 1.97% |
| 2024 Feb. | $4.02 | 2.23% |
| 2024 Mar. | $4.11 | 2.23% |
| 2024 Apr. | $4.20 | 2.24% |
| 2024 May. | $4.28 | 1.99% |
| 2024 Jun. | $4.33 | 1.14% |
| 2024 Jul. | $4.37 | 0.87% |
| 2024 Aug. | $4.42 | 1.19% |
| 2024 Sep. | $4.51 | 1.93% |
| 2024 Oct. | $4.63 | 2.70% |
| 2024 Nov. | $4.78 | 3.23% |
| 2024 Dec. | $4.94 | 3.44% |
ALLO : Allogene Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $5.11 | 3.36% |
| 2025 Feb. | $5.26 | 3.03% |
| 2025 Mar. | $5.39 | 2.47% |
| 2025 Apr. | $5.49 | 1.73% |
| 2025 May. | $5.54 | 0.91% |
| 2025 Jun. | $5.54 | 0.17% |
| 2025 Jul. | $5.52 | -0.52% |
| 2025 Aug. | $5.45 | -1.25% |
| 2025 Sep. | $5.35 | -1.70% |
| 2025 Oct. | $5.28 | -1.39% |
| 2025 Nov. | $5.23 | -1.00% |
| 2025 Dec. | $5.24 | 0.31% |
ALLO : Allogene Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $5.31 | 1.27% |
| 2026 Feb. | $5.43 | 2.30% |
| 2026 Mar. | $5.60 | 3.05% |
| 2026 Apr. | $5.78 | 3.34% |
| 2026 May. | $5.97 | 3.15% |
| 2026 Jun. | $6.13 | 2.67% |
| 2026 Jul. | $6.25 | 2.09% |
| 2026 Aug. | $6.35 | 1.58% |
| 2026 Sep. | $6.43 | 1.14% |
| 2026 Oct. | $6.48 | 0.77% |
| 2026 Nov. | $6.51 | 0.48% |
| 2026 Dec. | $6.53 | 0.42% |
ALLO : Allogene Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $6.56 | 0.36% |
| 2027 Feb. | $6.58 | 0.41% |
| 2027 Mar. | $6.62 | 0.56% |
| 2027 Apr. | $6.67 | 0.81% |
| 2027 May. | $6.75 | 1.10% |
| 2027 Jun. | $6.84 | 1.33% |
| 2027 Jul. | $6.94 | 1.43% |
| 2027 Aug. | $7.03 | 1.40% |
| 2027 Sep. | $7.12 | 1.26% |
| 2027 Oct. | $7.20 | 1.06% |
| 2027 Nov. | $7.26 | 0.86% |
| 2027 Dec. | $7.31 | 0.68% |
ALLO : Allogene Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $7.35 | 0.53% |
| 2028 Feb. | $7.38 | 0.44% |
| 2028 Mar. | $7.41 | 0.36% |
| 2028 Apr. | $7.43 | 0.30% |
| 2028 May. | $7.45 | 0.26% |
| 2028 Jun. | $7.47 | 0.26% |
| 2028 Jul. | $7.49 | 0.31% |
| 2028 Aug. | $7.52 | 0.37% |
| 2028 Sep. | $7.55 | 0.41% |
| 2028 Oct. | $7.58 | 0.43% |
| 2028 Nov. | $7.61 | 0.42% |
| 2028 Dec. | $7.64 | 0.39% |
ALLO : Allogene Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $7.67 | 0.35% |
| 2029 Feb. | $7.69 | 0.30% |
| 2029 Mar. | $7.71 | 0.26% |
| 2029 Apr. | $7.73 | 0.23% |
| 2029 May. | $7.75 | 0.22% |
| 2029 Jun. | $7.77 | 0.23% |
| 2029 Jul. | $7.78 | 0.25% |
| 2029 Aug. | $7.80 | 0.22% |
| 2029 Sep. | $7.81 | 0.10% |
| 2029 Oct. | $7.80 | -0.11% |
| 2029 Nov. | $7.78 | -0.29% |
| 2029 Dec. | $7.75 | -0.35% |
ALLO : Allogene Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $7.72 | -0.35% |
| 2030 Feb. | $7.70 | -0.32% |
| 2030 Mar. | $7.68 | -0.31% |
| 2030 Apr. | $7.65 | -0.32% |
| 2030 May. | $7.62 | -0.35% |
| 2030 Jun. | $7.59 | -0.41% |
| 2030 Jul. | $7.56 | -0.49% |
| 2030 Aug. | $7.51 | -0.60% |
| 2030 Sep. | $7.45 | -0.74% |
| 2030 Oct. | $7.39 | -0.90% |
| 2030 Nov. | $7.31 | -1.09% |
| 2030 Dec. | $7.21 | -1.27% |
ALLO : Allogene Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $7.11 | -1.42% |
| 2031 Feb. | $7.01 | -1.48% |
| 2031 Mar. | $6.91 | -1.44% |
| 2031 Apr. | $6.82 | -1.30% |
| 2031 May. | $6.74 | -1.07% |
| 2031 Jun. | $6.69 | -0.75% |
| 2031 Jul. | $6.66 | -0.42% |
| 2031 Aug. | $6.65 | -0.28% |
| 2031 Sep. | $6.62 | -0.34% |
| 2031 Oct. | $6.59 | -0.48% |
| 2031 Nov. | $6.55 | -0.64% |
| 2031 Dec. | $6.50 | -0.79% |
ALLO : Allogene Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $6.43 | -0.98% |
| 2032 Feb. | $6.35 | -1.25% |
| 2032 Mar. | $6.25 | -1.68% |
| 2032 Apr. | $6.10 | -2.30% |
| 2032 May. | $5.91 | -3.09% |
| 2032 Jun. | $5.68 | -3.97% |
| 2032 Jul. | $5.40 | -4.96% |
| 2032 Aug. | $5.09 | -5.69% |
| 2032 Sep. | $4.83 | -5.20% |
| 2032 Oct. | $4.60 | -4.74% |
| 2032 Nov. | $4.37 | -4.90% |
| 2032 Dec. | $4.15 | -5.06% |
ALLO : Allogene Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $3.95 | -4.88% |
| 2033 Feb. | $3.78 | -4.36% |
| 2033 Mar. | $3.64 | -3.69% |
| 2033 Apr. | $3.52 | -3.07% |
Frequently Asked Questions about Allogene Therapeutics stock forecast
Is Allogene Therapeutics a good long term stock?
From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2023 May. is $4.57442491243129 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2024 Apr. is $4.19955289381853 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2027 Apr. is $6.6749521514884 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2028 Apr. is $7.4282592341146 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2032 Apr. is $6.10201031168702 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2033 Apr. is $3.5244314135624
Is Allogene Therapeutics stock overvalued?
Allogene Therapeutics (ALLO) stock is expected to go DOWN . Therefore, Tudal would say that Allogene Therapeutics (ALLO) stock is overvalued.
Will Allogene Therapeutics stock price go up?
No. The Allogene Therapeutics stock price forecast for 2024 Apr. is $4.19955289381853
Is Allogene Therapeutics stock a good buy now?
Since closing price on 2023-03-31 is $4.94000005722046 and forecast for 2024 Apr. is $4.20, Allogene Therapeutics stock is not a good 1 year investment.